• Advertise
  • Contact Us
  • Subscribe
  • Follow
  • Follow
Pharmafile Logo
  • Home
  • Publications
    • European Biopharmaceutical Review
    • European Pharmaceutical Contractor (EPC)
    • Innovations in Pharmaceutical Technology (IPT)
    • International Clinical Trials (ICT)
    • Pharmaceutical Manufacturing and Packing Sourcer (PMPS)
    • Pharmafocus
    • Pharmafile
  • Conferences
  • News & Press Releases
  • Directory
  • Subscribe

Cambridge Epigenetix Introduces TrueMethyl Whole Genome Integrated Workflow for Epigenetic Analysis

Samedan Ltd|Oct 18, 2016| Uncategorized

Cambridge, UK, October 18, 2016: Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing...

Elsevier Launches New Release of Reaxys to Enable Chemists to Find the Shortest Path From Question to Answer

Samedan Ltd|Oct 18, 2016| Uncategorized

NEW YORK, October 18, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information...

Elsevier Opens Second Reaxys ChemSearch Challenge, Inviting Entrants to Compete in Solving Chemistry Conundrums

Samedan Ltd|Oct 18, 2016| Uncategorized

NEW YORK, October 18, 2016: Elsevier, a world-leading provider of scientific, technical and medical information...

ATCC and BioAgilytix Announce Partnership to Develop Custom Cell-based Assay Solutions to Support Biopharmaceutical R&D

Samedan Ltd|Oct 18, 2016| Uncategorized

MANASSAS, Va. and DURHAM, N.C, (Oct. 18, 2016) ó ATCC, a global leader in biological materials development, management...

Arquer Diagnostics and the University of Sunderland collaborate to extend application of cancer diagnostic

Samedan Ltd|Oct 18, 2016| Uncategorized

Sunderland, UK, 18 October 2016: Arquer Diagnostics Ltd, a diagnostic company which has developed a high sensitivity,...

Metrion Biosciences Expands Operations

Samedan Ltd|Oct 17, 2016| Uncategorized

Moves to new Laboratories at Granta Park, Cambridge Appoints Dr Andrew Southan as Head of Commercial Operations...

Genomics plc Appointed as Analysis Partner for Genomics England GENE Consortium

Samedan Ltd|Oct 17, 2016| Uncategorized

Oxford, UK, 17 October 2016: Genomics plc, a leading analysis company developing an integrated platform to uncover the...

Enterprise Therapeutics appoints Dr John Ford as CEO

Samedan Ltd|Oct 17, 2016| Uncategorized

Brighton, UK - October 17, 2016: Enterprise Therapeutics Ltd, a drug discovery company dedicated to the research and...

Optibrium Introduces Database Query Interface for StarDrop

Samedan Ltd|Oct 13, 2016| Uncategorized

CAMBRIDGE, UK, 13 October 2016 - Optibrium™, a developer of software for small molecule drug discovery and...

Natoli Announces 2017 Technical Training Course Schedule

Samedan Ltd|Oct 13, 2016| Uncategorized

ST. CHARLES, MO., U.S. (Oct. 13, 2016) ó Space is limited is a phrase youíll be hearing a lot more of in the coming...

PhoreMost Ltd and University of Cambridge collaborate to identiovative drug targets for neurodegenerative disease

Samedan Ltd|Oct 12, 2016| Uncategorized

Cambridge, UK, 12 October 2016: PhoreMost Ltd (PhoreMost), a biopharmaceutical company dedicated to drugging...

ERT Bolsters Data Leadership

Samedan Ltd|Oct 12, 2016| Uncategorized

PHILADELPHIA - October 12, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in...

Older Entries
Next Entries
European Biopharmaceutical Review
European Pharmaceutical Contractor
Innovations in Pharmaceutical Technology
International Clinical Trials
Pharmaceutical Manufacturing and Packing Sourcer
Pharmafile
Pharmafile.com
Pharmafocus
  • About Samedan
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (UK)
All content copyright © Samedan Ltd 2026
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}